Body dysmorphic disorder (BDD) changes how a person attends to, interprets, and responds to a perceived defect in appearance. Cosmetic procedures change physical features. When a person with BDD seeks surgery, injections, dermatologic treatment, or repeated corrective procedures, the clinical question is whether an alteration of the body can satisfy a concern maintained by a psychiatric disorder. The answer depends on careful assessment of the person's symptoms, motivations, ability to give informed consent, physical indications, treatment history, and safety. For clinically significant BDD, psychological assessment and evidence-based mental health care are central, and an elective cosmetic procedure should not be treated as a substitute for BDD treatment. NICE CG31.
The same appearance concern can occur in several different circumstances: an ordinary aesthetic preference, distress about a visible condition, a medically indicated reconstructive need, or BDD. A request for cosmetic treatment does not establish a diagnosis. Conversely, a small or clinically subtle physical difference can accompany severe preoccupation, repetitive checking, avoidance, shame, impaired functioning, and high suicide risk. A sensitive clinical pathway takes both bodily health and psychological suffering seriously. NICE CG31.
What is the relationship between BDD and cosmetic procedures?
BDD is characterized by a distressing preoccupation with one or more perceived flaws in physical appearance that are not observable or appear slight to others, together with repetitive behaviors or mental acts such as mirror checking, camouflaging, seeking reassurance, or comparison. The concern causes clinically significant distress or impairment and is not better explained by concerns about body fat or weight in an eating disorder. The degree of insight varies, including cases in which appearance beliefs are held with very strong conviction. Diagnosis belongs to a qualified clinician who can assess the entire presentation. NICE CG31.
Cosmetic procedures include aesthetic surgery, minimally invasive injections, laser and dermatologic interventions, cosmetic dentistry, hair procedures, and other attempts to change appearance. Reconstructive procedures can serve additional functional and restorative purposes, and the patient's clinical circumstances must be evaluated separately. The connection with BDD arises when someone expects a physical alteration to end persistent intrusive appearance concerns, social fear, a sense of defectiveness, or a pattern of compulsive monitoring. A technically successful intervention may change the feature while leaving the processes that sustain distress intact. Phillips et al. (2001).
This is an issue of indications, expectations, and clinical mechanisms. It is also a patient-safety issue: an irreversible intervention has a different risk profile from psychological treatment, and a sequence of operations or corrections can carry accumulating medical, emotional, and financial costs. The appropriate clinical response is an individualized, documented evaluation, followed by shared decision-making and coordinated care. Medical Board of Australia (2023).
How frequently is BDD found in cosmetic settings?
The evidence from clinical and surgical populations
BDD symptoms and positive screening results occur more often in selected cosmetic and dermatologic settings than in community samples. A systematic review by Veale and colleagues estimated weighted BDD prevalence around 1.9% in community adults, compared with 13.2% in general cosmetic surgery, 20.1% in rhinoplasty, 9.2% in cosmetic dermatology, and 11.3% in general dermatology outpatient settings. These are setting-specific estimates based on the studies available, not probabilities that apply to any one person seeking care. Veale et al. (2016).
A meta-analysis of 48 studies involving 14,913 cosmetic-surgery applicants estimated pooled BDD prevalence at 19.2% (95% confidence interval 15.8%–23.0%). The 2022 systematic review. A broader 2024 meta-analysis included 65 studies and 17,107 participants and estimated a pooled rate of 18.6% (95% confidence interval 15.1%–22.4%) across aesthetic and reconstructive plastic-surgery populations. Kaleeny and Janis (2024).
These estimates require interpretation. Included studies used different diagnostic interviews, screening questionnaires, specialties, countries, and enrollment strategies. A positive screening questionnaire is not the same as a confirmed psychiatric diagnosis. Studies with different case definitions and patient-selection mechanisms may produce quite different percentages. The clinically useful conclusion is that cosmetic settings need reliable recognition and referral pathways; a pooled prevalence figure should never be used to label an individual patient. Kaleeny and Janis (2024).
What newer research adds
In a July 2026 peer-reviewed observational study, Diele and colleagues compared an online group with probable BDD based on self-report criteria (1,837 people), a subclinical group (392), and a control group (166). Among those with probable BDD, 29.5% reported a previous cosmetic procedure and 68.0% reported interest in future surgery. Satisfaction with prior procedures was relatively low. Stronger symptoms and conviction about appearance beliefs were related to intentions to seek surgery; the authors also found substantial under-recognition of formal BDD diagnosis. Diele et al. (2026).
That study describes self-selected online respondents and relies on self-report rather than a diagnostic examination of every participant. Its reported history of procedures among people with probable BDD cannot be substituted for the prevalence of BDD among patients entering a surgical clinic. These are opposite conditional questions with different denominators. The findings support clinical attention to severity, conviction, and repeated procedure seeking while leaving causation and long-term individual prognosis unresolved. Diele et al. (2026).
Why may changing appearance fail to relieve BDD?
Selective attention, appraisal, and perceptual interpretation
BDD involves patterns of attention and interpretation in which one feature becomes exceptionally salient and is evaluated through rigid assumptions about appearance, worth, and social acceptance. People may notice fine details in photographs or mirrors, interpret ordinary variation as proof of a major defect, or overestimate the importance others assign to a feature. This explanatory framework comes from cognitive-behavioral models and clinical observation. Its specific neural and perceptual components remain an active area of research; there is no single visual-processing finding that can diagnose BDD.
Physical alteration can produce a meaningful cosmetic outcome without changing the underlying rule, such as the belief that social safety requires perfect symmetry. The person may continue checking the original feature, shift attention to a different feature, or reinterpret minor residual asymmetry as another serious defect. This is one reason that appearance-focused care may leave the disorder's central distress active. Phillips et al. (2001).
Compulsive checking, avoidance, and reassurance
Repeated mirror checking, comparison, photography, editing, consultation seeking, skin manipulation, and requests for reassurance can function as attempts to reduce uncertainty or distress. Relief may be short-lived, reinforcing further monitoring. Avoiding mirrors, appointments, social events, or photographs can also preserve fears by preventing corrective learning. Seeking another procedure can become part of the same cycle, especially when an initially satisfying result is followed by renewed uncertainty.
The function of a behavior matters more than its superficial appearance. A person may take a photograph for an ordinary social reason; another may take hundreds of photographs to obtain temporary certainty that a perceived flaw has disappeared. Assessment asks how much time is occupied, what triggers the behavior, what happens when the behavior is resisted, and whether work, relationships, sleep, and daily functioning are affected. NICE CG31.
Expectations and psychological outcomes
Some people imagine that a procedure will resolve several problems simultaneously: attractiveness, belonging, employment, relationships, self-esteem, anxiety, or avoidance. An operation is capable of modifying specified anatomy within medical limits, but it cannot reliably deliver a broad psychological transformation. A clinician should clarify what the patient believes will change physically, how the patient expects to feel afterward, and what would count as an acceptable result. Expectations that hinge on absolute perfection or guarantee social acceptance signal the need for deeper assessment. Medical Board of Australia (2023).
What do studies show about outcomes after cosmetic treatment?
Early clinical evidence
In a clinical study of 289 individuals with BDD, Phillips and colleagues reported extensive use of nonpsychiatric medical treatments, including dermatologic procedures and surgery. Most participants who received such care reported little improvement in their BDD symptoms. The study was observational and based on clinical histories; it established an important treatment-pattern concern without providing the causal certainty of a randomized trial. Phillips et al. (2001).
Similar work and later reviews have raised concerns about disappointment, persistent preoccupation, recurrent cosmetic requests, and difficulty interpreting technical success when psychological symptoms persist. Yet published outcome series often differ in selection criteria, operation type, follow-up length, BDD severity, and whether the initial diagnosis was made by a specialist. Evidence should therefore be read in terms of the outcome measured, rather than compressed into a claim that every patient has the same result.
Can surgery ever help someone with BDD?
The evidence does not justify promising a cure through cosmetic surgery. Selected individuals may report satisfaction with a particular cosmetic change or short-term improvement in some symptoms. However, improvement in satisfaction with the treated feature, symptom ratings, and durable remission of BDD are distinct endpoints. A 2025 conference-supplement abstract describing a review of eight studies and 872 patients reported possible short-term benefits for some patients, less consistent long-term remission, and risk of deterioration in subsets with severe symptoms. As a conference abstract, it supplies limited methodological detail and merits less weight than a fully peer-reviewed clinical guideline or a definitive prospective trial. BJS abstract (2025).
There is no robust evidence that elective cosmetic intervention serves as an evidence-based primary treatment for established BDD. The decision to defer an elective procedure while specialized evaluation and treatment occur reflects that evidence base and accepted safety guidance. Treatment decisions concerning a separate, medically indicated functional problem should be individualized by the relevant medical and psychiatric professionals rather than treated as identical to elective appearance enhancement. NICE CG31.
Why before-and-after satisfaction can be misleading
Patient-reported satisfaction is valuable, but interpretation requires an appropriate baseline, independently assessed psychiatric diagnosis, defined physical outcome, validated psychiatric symptom measures, and follow-up beyond the immediate recovery period. Cosmetic satisfaction can increase while compulsive behavior or avoidance remains severe. A person can also feel distressed soon after surgery because of normal swelling, pain, or recovery uncertainty without meeting criteria for BDD. A rigorous study must separate these trajectories.
Other biases affect surgical outcomes research: people who accept surgery may differ from those referred for psychological treatment; dissatisfied patients may be more likely to seek repeat care; and poorly documented preoperative severity may obscure who was most at risk. Nonrandom treatment selection and short follow-up substantially limit causal claims about surgery's effects on the disorder.
Recognizing clinically significant BDD before a procedure
The critical questions in a consultation
A useful preprocedure interview explores the specific perceived defect, hours spent thinking about it, repetitive rituals and avoidance, daily impairment, onset and duration, previous treatments, prior procedures, and the effect of these procedures on distress. It explores anxiety, depression, substance use, eating-related symptoms, and immediate safety. The clinician also asks what the person hopes a procedure will change and whether they can tolerate an imperfect or partially satisfying outcome. NICE CG31.
NICE advises considering BDD in people with minor visible blemishes who seek cosmetic or dermatologic treatment and recommends asking about excessive preoccupation and its impact on work and relationships. When BDD is suspected or diagnosed in someone seeking cosmetic surgery or dermatologic treatment, NICE recommends assessment by a mental health professional with expertise in BDD. The aim is clinical formulation and safe care, not confrontation or dismissal of the person's concerns. NICE CG31.
Screening tools and their limits
Validated tools used in cosmetic settings include the Body Dysmorphic Disorder Questionnaire (BDDQ) and adapted versions, the BDDQ–Aesthetic Surgery (BDDQ-AS), the BDDQ–Dermatology Version (BDDQ-DV), the Cosmetic Procedure Screening Questionnaire (COPS), and other symptom measures. A 2024 review of screening in plastic surgery identified six instruments with validation evidence for relevant settings. Choice depends on the patient population, setting, language, licensing and intended use. Screening review (2024).
Screening estimates the likelihood of concern requiring further evaluation; it does not adjudicate DSM or ICD criteria, measure decision-making capacity, or determine whether an operation is legally permitted. A negative screen cannot override clear clinical signs, and a positive result should initiate an appropriately skilled interview instead of automatic labeling. Adapted thresholds can behave differently across populations and cultural contexts. Staff need a written plan for documentation, confidentiality, referral, and follow-up.
Clinical diagnosis and differential assessment
A BDD assessment examines preoccupation, repetitive mental or behavioral acts, distress or functional impairment, and whether the appearance concern is better explained by another disorder. Eating-disorder psychopathology may center on body weight and shape in relation to eating, whereas BDD concerns often center on particular perceived defects; comorbidity is possible. Social anxiety may involve broad fear of negative evaluation; BDD often adds a focused perceived defect and appearance-related rituals. OCD and BDD can overlap in repetitive behaviors, yet differ in the typical content of obsessions and associated beliefs. These distinctions are established through clinical history rather than a single self-report score.
Clinicians also evaluate actual skin disease, dermatologic inflammation, injuries, scarring, a congenital variation, a functional deformity, or a postsurgical complication. BDD can coexist with a physical condition. A patient with visible differences deserves appropriate physical care, pain treatment, functional assessment, and attention to stigma. The amount of visible difference alone cannot measure psychological need. NICE CG31.
Decision-making capacity, informed consent, and procedure suitability
A consent process adapted to psychiatric risk
Valid informed consent requires understanding the procedure, material risks, alternatives, limits of reversibility, likely recovery, and realistic outcomes. The clinician should explore whether the patient can weigh those considerations and make a voluntary choice. Poor insight or a BDD diagnosis does not automatically establish lack of decision-making capacity; capacity is specific to the decision and should be evaluated where there is concern. BDD may nonetheless affect expectations, symptom reporting, or interpretation of risk, and that warrants careful documentation and specialist input.
Discussion should explicitly distinguish a surgical endpoint, such as a measurable anatomical change, from psychological endpoints such as relief of obsessive preoccupation, restoration of relationships, and recovery from avoidance. Written information, opportunities for questions, and time to consider alternatives support deliberation. The surgeon remains accountable for deciding whether an intervention offers a reasonable balance of benefits and harms; referral to a psychologist does not transfer that responsibility. Medical Board of Australia (2023).
When an elective intervention should be deferred
Deferral is clinically justified when there is suspected or active BDD requiring specialist assessment; untreated severe psychiatric symptoms; significant suicidal risk; unstable expectations; inability to engage with consent; or escalating repeated requests driven by unsatisfied preoccupation. The team should explain the reason, assess immediate safety, provide an accessible specialist referral, and offer a specific route back for discussion of legitimate physical concerns. Merely sending the patient away can magnify shame and delay appropriate treatment.
National regulations vary. In Australia, Medical Board guidance requires practitioners who perform cosmetic surgery to assess psychological suitability and use validated BDD screening; significant concerns prompt referral for independent evaluation, and practitioners must decline surgery when they judge it contrary to the patient's best interests. For nonsurgical cosmetic procedures, a clinical psychological assessment is required, although the same mandatory validated-tool provision does not apply. These rules describe the Australian system; they should not be presented as universal law. Medical Board FAQ (2023).
Red flags that require assessment, not accusation
Features that warrant attention include spending hours each day thinking about an apparently minor feature, repeated mirror or image checking, extensive camouflage, refusal to appear in public, expectations that a procedure will change an entire life, requests for correction immediately after an adequate outcome, and a history of procedures that failed to relieve central distress. Expressed desperation, severe depression, suicidal thoughts, or threats of self-harm require a clinical safety response. None of these observations alone proves a diagnosis or malicious intent, and clinical staff should avoid stigmatizing terms for distressed patients. NICE CG31.
Psychological treatment and coordinated clinical care
Cognitive behavioral therapy developed for BDD
BDD-focused cognitive behavioral therapy (CBT) addresses appearance-related interpretations, attentional fixation, rituals, avoidance, and the belief that certainty about appearance is necessary for functioning. Treatment may combine individualized formulation, cognitive work, exposure and response prevention, reduction of safety behaviors, and attention to entrenched shame or social withdrawal. Exposure is designed collaboratively and paced for safety; it is not an instruction to force a person into humiliating situations.
Randomized trials provide evidence for specialized CBT. A trial comparing CBT with anxiety management found superior BDD outcomes for the CBT approach, and a later randomized clinical trial compared therapist-delivered CBT with supportive psychotherapy, strengthening the treatment evidence base. Clinical improvements are assessed through symptom and functioning measures over time. Veale et al. (2014); Wilhelm et al. (2019).
In a procedure-focused formulation, therapy can explore the anticipated meaning of cosmetic change, the sequence of checking and reassurance, prior disappointment, how the patient interprets photographs, and the possibility that another operation will reproduce the same pattern. Patients can make an informed appearance decision more effectively when intrusive symptoms and urgency have eased.
Medication and psychiatric follow-up
Selective serotonin reuptake inhibitors (SSRIs) are an evidence-supported treatment option for BDD, particularly where symptoms cause moderate to severe impairment or where combined care is indicated. NICE recommends CBT with exposure and response prevention for mild adult BDD; an SSRI or more intensive CBT for moderate adult BDD; and combined treatment for severe adult BDD. The guidance names fluoxetine as the initial medication option for adults when pharmacotherapy is selected, noting licensing considerations. Drug selection, contraindications, titration, monitoring, and duration require a prescribing clinician. NICE CG31.
An SSRI should not be started, stopped, or adjusted independently based on material in a cosmetic consultation or online article. Clinicians monitor activation, side effects, emerging suicidal thoughts, drug interactions, and adherence, particularly at initiation and changes of dose. Psychological and pharmacologic plans should account for depression, anxiety, obsessive-compulsive symptoms, substance use, and any eating disorder. Coordinating these needs avoids treating only the most visually obvious complaint.
A multidisciplinary pathway
A safe care model involves an initial cosmetic or dermatologic clinician, an appropriately trained mental health assessor, a primary care clinician when relevant, and the patient's chosen support network where consent permits. The referring clinician records observations and the physical indication; the mental health clinician undertakes diagnostic and risk assessment; the team communicates a clear recommendation about treatment, deferral, and follow-up. NICE specifically calls for cooperation between BDD specialist teams, surgeons, and dermatology services in screening and referral. NICE CG31.
When the patient has already undergone a procedure, the pathway also includes objective evaluation of surgical healing or complications. Physical pain, infection, scarring, or loss of function demands appropriate medical attention on its own merits. Concurrent psychiatric support can address recurring preoccupation, depression, avoidance, or compulsive requests without minimizing a real postoperative problem.
Different cosmetic contexts create different questions
Rhinoplasty, facial aesthetics, and perceived asymmetry
Requests focused on the nose, facial symmetry, pores, skin texture, jawline, or perceived disproportion are common reasons for appearance consultation. In selected rhinoplasty cohorts, earlier pooled estimates have been higher than general cosmetic surgery populations, supporting particular vigilance while acknowledging methodological heterogeneity. Photographic measurements and anatomical assessment can establish what can physically change; psychiatric assessment establishes whether the distress and expectations arise from BDD or another process. Veale et al. (2016).
Dermatology, injections, and non-surgical treatments
Laser procedures, cosmetic injectables, antiaging treatments, and dermatologic consultations can involve the same psychological vulnerabilities as surgery. A procedure with less invasive technique can still produce dissatisfaction, adverse effects, financial strain, or repeated treatment seeking. Dermatologic conditions themselves may also carry substantial social and emotional burdens. Clinical evaluation should address the skin disease or lesion, the desired change, psychiatric features, and a reasonable plan for follow-up. Medical Board of Australia (2023).
Hair restoration, cosmetic dentistry, and body-contouring requests
Appearance concerns may focus on hair density, teeth, musculature, body contour, or a feature that acquires unusual significance in a person's identity. The meaning of the concern and the presence of distressing repetitive behaviors matter more than the specialty offering a procedure. Muscle dysmorphia is a recognized BDD presentation centered on perceived insufficient muscularity; where eating or exercise behaviors create medical hazards, those behaviors require their own assessment. Specialized medical and psychiatric clinicians should establish the principal treatment needs before invasive elective choices.
Reconstructive care and visible difference
Reconstructive interventions for trauma, cancer, congenital differences, burns, or functional limitations frequently have purposes that extend beyond appearance preference. Their benefits may include function, comfort, restoration, and participation. Psychological support can help patients navigate grief, stigma, identity, and changing self-perception, whether or not BDD is present. The existence of BDD symptoms should prompt coordinated assessment, while clinically indicated treatment decisions remain sensitive to urgency, functionality, and individual goals.
Psychological, social, and digital pressures
Appearance ideals are shaped by social norms, interpersonal comments, commercial advertising, and increasingly edited or synthetic images. People can internalize narrow ideals or compare themselves repeatedly with apparently flawless faces and bodies. Such exposures may exacerbate concerns in vulnerable individuals; they do not, by themselves, diagnose BDD. Evidence about AI-generated ideals and beauty filters should be evaluated according to the actual study design, exposure, and outcome measured rather than attributed a uniform effect.
The commercial context of cosmetic treatment creates a special responsibility. Before-and-after imagery, financing offers, social proof, algorithmic recommendations, and promises of transformation may raise urgency or influence perceived expectations. Ethical care includes accurate risk communication, avoidance of guarantees about mental health, attention to financial conflicts of interest, and documentation of how the person's motivations were explored. Medical Board of Australia (2023).
Gender, age, disability, socioeconomic position, racialization, and cultural norms influence what people are told about attractiveness and which services they can access. Research often overrepresents adult women in cosmetic clinics; the 2026 online study identified different procedural patterns for women and men but had limitations for broader gender-diverse and population-level inference. Practice should avoid assuming that an appearance concern is trivial in one group or pathological in another. Diele et al. (2026).
Suicide risk, severe distress, and urgent assessment
BDD can be associated with severe depression, social withdrawal, suicidal ideation, and self-harm. Clinical assessment must evaluate the individual's current thoughts, intent, plans, means, past behavior, protective factors, and comorbid conditions. NICE explicitly recommends suicide and self-harm assessment in diagnosed BDD, especially with depression, and more intensive monitoring when appropriate treatment is absent or ineffective. NICE CG31.
A person expressing imminent intent to harm themselves needs urgent local emergency assessment and immediate professional support. A cosmetic consultation cannot replace crisis care. Nonjudgmental communication, safe handoff, and continuity are central. Clinicians should document the assessment and ensure the patient knows how to access prompt help. Symptom severity is never inferred solely from the appearance of the physical feature.
Questions patients and clinicians frequently ask
Is wanting cosmetic surgery a sign of body dysmorphic disorder?
No. People request cosmetic care for many reasons. BDD is identified through a clinical pattern of excessive preoccupation, repetitive responses, impairment, and differential diagnosis. Aesthetic preference and psychiatric disorder may coexist, but one cannot be inferred from the other. NICE CG31.
Can a surgeon diagnose BDD from a questionnaire?
A validated questionnaire identifies individuals who may need specialist assessment. It does not establish a final diagnosis, consent capacity, or procedure suitability by itself. Appropriate clinical assessment considers symptoms, impairment, risk, and alternative explanations. Screening review (2024).
Why might someone seek another procedure after a successful operation?
The operation may have achieved its anatomical goal while intrusive worries, checking, comparison, or an inflexible ideal continued. The person may focus on a residual detail or another feature. A clinician should assess both the physical result and the ongoing symptom pattern before offering another intervention. Phillips et al. (2001).
Is cosmetic surgery always ruled out for someone who has BDD?
The critical task is evaluation of current symptoms, psychological risk, treatment response, procedure indications, consent, and expected benefits. Elective appearance treatment is not established as a therapy for BDD, and suspected or active BDD generally warrants specialist assessment and often deferral. Medical or reconstructive indications require their own individualized interdisciplinary decisions. NICE CG31.
Can someone pursue dermatologic care while receiving BDD treatment?
Yes. Necessary physical care and mental health treatment can proceed together. Coordination helps clarify which symptoms are caused by a physical condition, which are maintained by BDD, and what each intervention is designed to improve. NICE CG31.
Which treatment directly addresses the disorder?
BDD-focused CBT and, when clinically indicated, SSRI medication have the strongest established treatment roles. Care intensity depends on impairment, age, comorbidity, and individual response. A psychiatrist, psychologist, or appropriately trained team should supervise care. NICE CG31; Wilhelm et al. (2019).
What remains uncertain in the science?
The prevalence literature is heterogeneous; screening thresholds, specialist settings, cultural differences, and recruitment mechanisms affect estimates. Prospective research needs clearer separation of individuals with independently diagnosed BDD, subthreshold symptoms, ordinary dissatisfaction, and visible physical conditions. Better data are also needed on procedure type, objective outcome, psychiatric symptom trajectories, and complications over longer follow-up.
Published studies cannot fully determine which highly selected patients with past BDD might achieve durable psychological improvement from a given procedure after effective psychiatric treatment. The ethical clinical pathway should therefore remain based on independently assessed symptoms, measured functional needs, realistic expectations, and transparent risk communication. Evidence for BDD-specific CBT and clinical psychiatric assessment is substantially stronger than evidence for cosmetic surgery as treatment of BDD. Wilhelm et al. (2019); Kaleeny and Janis (2024).
Clinical conclusion
BDD and cosmetic procedures intersect at a demanding point of clinical care: a patient may have genuine suffering, strong confidence that a physical change is the solution, and a request for an intervention that cannot reliably resolve the disorder. Evidence supports active recognition, validated screening as an initial step, specialist diagnostic assessment when concerns arise, individualized evaluation of medical indications, and treatment directed at BDD itself. Surgeons, dermatologists, primary care clinicians, and mental health professionals share responsibility for a respectful pathway in which physical care and psychological safety are assessed on their own terms. NICE CG31.
Related Articles
Body Dysmorphic Disorder: Symptoms, Diagnosis, and Treatment — Diagnostic criteria, severity, differential assessment, and core treatments of BDD.
Body Dysmorphic Disorder vs Body Dissatisfaction: What Is the Difference? — Clinical boundaries between ordinary negative body evaluation and a psychiatric disorder.
CBT for Body Dysmorphic Disorder: Evidence and Treatment Approaches — Clinical mechanisms and evidence for BDD-specific psychotherapy.
Cluster Body Image and Appearance Psychology — The parent scientific chapter on appearance evaluation, embodied identity, stigma, and clinical care.
References
Diele, J., Witte, A., Barenbrügge, J., Schulte, J., and Buhlmann, U. (2026). Aesthetic surgeries in body dysmorphic disorder symptoms: Clinical and gender-related patterns. Journal of Obsessive-Compulsive and Related Disorders, 50, 101031. https://doi.org/10.1016/j.jocrd.2026.101031.
Kaleeny, J. D., and Janis, J. E. (2024). Body dysmorphic disorder in aesthetic and reconstructive plastic surgery—A systematic review and meta-analysis. Healthcare, 12(13), 1333. https://doi.org/10.3390/healthcare12131333.
Medical Board of Australia. (2023). FAQ: Guidelines for registered medical practitioners who perform cosmetic surgery and procedures—Patient assessment and BDD screening. Official guidance.
Medical Board of Australia. (2023). Guidelines for registered medical practitioners who perform cosmetic surgery and procedures. Official guidance.
National Institute for Health and Care Excellence (NICE). (2005, current online recommendations). Obsessive-compulsive disorder and body dysmorphic disorder: Treatment, CG31. https://www.nice.org.uk/guidance/cg31/chapter/Recommendations.
Phillips, K. A., Grant, J., Siniscalchi, J., and Albertini, R. S. (2001). Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder. Psychosomatics, 42(6), 504–510. https://doi.org/10.1176/appi.psy.42.6.504.
Salari, N., Kazeminia, M., Heydari, M., Darvishi, N., Ghasemi, H., Shohaimi, S., and Mohammadi, M. (2022). Body dysmorphic disorder in individuals requesting cosmetic surgery: A systematic review and meta-analysis. Journal of Plastic, Reconstructive and Aesthetic Surgery, 75(7), 2325–2336. https://doi.org/10.1016/j.bjps.2022.04.098.
Thomson, D. R., Thomson, N. E. V., and Southwick, G. (2024). Screening for Body Dysmorphic Disorder in Plastic Surgery Patients. Aesthetic Plastic Surgery, 48, 2738–2743. https://doi.org/10.1007/s00266-024-03959-6.
Veale, D., et al. (2014). Efficacy of cognitive behaviour therapy versus anxiety management for body dysmorphic disorder: A randomised controlled trial. Psychotherapy and Psychosomatics, 83(6), 341–353. https://doi.org/10.1159/000360740.
Veale, D., Gledhill, L. J., Christodoulou, P., and Hodsoll, J. (2016). Body dysmorphic disorder in different settings: A systematic review and estimated weighted prevalence. Body Image, 18, 168–186. https://doi.org/10.1016/j.bodyim.2016.07.003.
Wilhelm, S., et al. (2019). Efficacy and posttreatment effects of therapist-delivered cognitive behavioral therapy vs supportive psychotherapy for adults with body dysmorphic disorder: A randomized clinical trial. JAMA Psychiatry, 76(4), 363–373. https://doi.org/10.1001/jamapsychiatry.2018.4156.
Yong, Z. Y., Lim, H. B., Faderani, R., Kanapathy, M., and Mosahebi, A. (2025). Impact of cosmetic surgery on BDD symptoms, QoL, and psychological impact in BDD-diagnosed patients: A systematic review [conference abstract]. British Journal of Surgery, 112(Supplement 10), znaf128.528. https://doi.org/10.1093/bjs/znaf128.528.